Form Type: 4

SEC EDGAR Link
Acccession Number:0001213900-19-008815
Date:2019-05-14
Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
Original Submission Date:

Reporting Person:

KELLY PAUL EDWARD
C/O RELMADA THERAPEUTICS, INC.
880 THIRD AVENUE, 12TH FLOOR NEW YORK,, NY 10022

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-14 P 100,000 a $1.50 488,483 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
WARRANT 2.25 2019-05-14 deemed execution date P 50,000 (a) 2019-05-14 2024-05-14 common stock 50,000 $2.25 50,000 direct
Footnotes
IDfootnote

Elevate your investments